CRISPR–Cas9 nucleases have been applied in gene drive constructs to target endogenous sequences of the human malaria vectorsA. gambiae and A. stephensi with the objective of vector control.
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.
The parasite Plasmodium vivax sickens approximately 75 million people a year in Asia and the Americas. New genetic evidence shows how the parasite might have gotten its start: in African ape and human populations, before hitching a ride off the continent with early human migrants.
The kit is designed to pick up a range of pathogens in humans, animals and plants, but it will first be used to detect malaria.
Substantial reductions in malaria incidence in sub-Saharan Africa have been achieved with massive deployment of long-lasting insecticidal nets, but pyrethroid resistance threatens control
Paraguay is the first South American country to eradicate malaria, but cases in neighboring countries are mounting.
Scientists have sequenced and annotated the first complete mitochondrial genome of Anopheles funestus, one of the main vectors of malaria in sub-Saharan Africa.
The drug - called tafenoquine - prevents malaria relapses by about 70 percent, clinical studies have shown.
Scientists are racing to stamp out the disease in southeast Asia before unstoppable strains spread.
Krintafel is the first new treatment for P. vivax malaria in more than 60 years.